Turkey and Havarti sandwiches. Prepared by Gourmet Classic Salads 240 E Bullard Ave. Lake Wales, FL 33853
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2086-2017.
FDA Environmental samples and finished product collected at the firm revealed the presence of Listeria monocytogenes. The firm is recalling the products due to the potential for Listeria contamination.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2086-2017.
Recall ongoing. Follow firm instructions.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Gourmet Classic Salads, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2086-2017.
Gourmet Classic Salads, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Gourmet Classic Salads, Inc. Recall FAQ
Gourmet Classic Salads, Inc. is the subject of a meat & poultry safety report: Turkey and Havarti sandwiches. Prepared by Gourmet Classic Salads 240 E Bullard Ave. Lake Wales, FL 33853. The notice was published on March 20, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 901 units are potentially affected.